Physician profile
John Higgins
NPI 1679531925
$734.26
in general payments reported to CMS, 2019-2025
8 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $57.75 · 2021: $186 · 2022: $23.37 · 2023: $127 · 2024: $61.32 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $295.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $348.68 | 2019-2025 | |
| Boston Scientific Corporation | $115.73 | 2019-2021 | |
| Shockwave Medical, INC | $92.50 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $61.32 | 2024 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals Lp | $57.82 | 2022-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $23.12 | 2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $17.63 | 2025 | |
| Teleflex LLC | $17.46 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Higgins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.